Scarica l'app Stockscreener
3.51
2.77%
-0.10
Dopo l'orario di chiusura:
3.20
-0.31
-8.83%
Precedente Chiudi:
$3.61
Aprire:
$3.6
Volume 24 ore:
56,301
Relative Volume:
0.26
Capitalizzazione di mercato:
$95.04M
Reddito:
-
Utile/perdita netta:
$-49.81M
Rapporto P/E:
-1.628
EPS:
-2.156
Flusso di cassa netto:
$-42.93M
1 W Prestazione:
-7.87%
1M Prestazione:
+14.71%
6M Prestazione:
+12.86%
1 anno Prestazione:
-73.81%
Intervallo 1D:
$3.41
$3.60
Intervallo di 1 settimana:
$3.41
$3.92
Portata 52W:
$1.60
$15.04
Alto Neuroscience Inc Stock (ANRO) Company Profile
Nome
Alto Neuroscience Inc
Settore
Industria
Telefono
773-255-5012
Indirizzo
650 CASTRO STREET, SUITE 450, MOUNTAIN VIEW
Confronta ANRO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ANRO
Alto Neuroscience Inc
|
3.51 | 105.06M | 0 | -49.81M | -42.93M | -2.156 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Alto Neuroscience Inc Stock (ANRO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-10-23 | Downgrade | Rodman & Renshaw | Buy → Neutral |
| 2024-10-23 | Downgrade | Wedbush | Outperform → Neutral |
| 2024-09-03 | Iniziato | Wedbush | Outperform |
| 2024-02-27 | Iniziato | Jefferies | Buy |
| 2024-02-27 | Iniziato | Robert W. Baird | Outperform |
| 2024-02-27 | Iniziato | Stifel | Buy |
| 2024-02-27 | Iniziato | TD Cowen | Outperform |
| 2024-02-27 | Iniziato | William Blair | Outperform |
Mostra tutto
Alto Neuroscience Inc Borsa (ANRO) Ultime notizie
Alto Neuroscience, Inc. Investors: Please contact the - GlobeNewswire
Alto Neuroscience, Inc. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsANRO - The Globe and Mail
PDE4B Inhibitor Market Poised for Strong Growth by 2034 | DelveInsight - GlobeNewswire Inc.
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Alto Neuroscience - FinancialContent
Published on: 2025-09-03 09:03:31 - Newser
Pomerantz Law Firm Announces the Filing of a Class Action Against Alto Neuroscience, Inc. and Certain OfficersANRO - PR Newswire
ALTO CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire
ANRO SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Alto Neuroscience, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Backtesting results for Alto Neuroscience Inc. trading strategies2025 Retail Activity & AI Driven Price Forecasts - Newser
Is Alto Neuroscience Inc.’s growth already priced inJuly 2025 Levels & Weekly Breakout Opportunity Watchlist - khodrobank.com
What machine learning models say about Alto Neuroscience Inc.2025 Big Picture & Real-Time Stock Entry Alerts - Newser
ANRO DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages - GlobeNewswire
ANRO STOCK NEWS: Alto Neuroscience, Inc. Investors are Reminded of the Pending Lead Plaintiff Deadline; Contact Robbins LLP for Information on Leading the Class Action - WV News
Shareholders of Alto Neuroscience, Inc. (ANRO): Protect Your Rights Before September 19, 2025Contact Levi & Korsinsky - The Globe and Mail
Bearish Setup: Should I buy Alto Neuroscience Inc. stock nowEarnings Miss & Reliable Price Breakout Signals - khodrobank.com
Investors SueWallSt Over Alto Neuroscience, Inc. Stock DropContact Levi & Korsinsky to Join - ACCESS Newswire
What are analysts’ price targets for Alto Neuroscience Inc.July 2025 EndofMonth & Weekly Watchlist for Consistent Profits - kpenews.com
Alto Neuroscience Inc. stock daily chart insightsMarket Activity Recap & Proven Capital Preservation Tips - Newser
Using Python tools to backtest Alto Neuroscience Inc. strategiesWeekly Trend Recap & Capital Efficient Trade Techniques - Newser
Is Alto Neuroscience Inc. forming a bullish divergence2025 Analyst Calls & Advanced Technical Signal Analysis - خودرو بانک
INVESTOR ALERT: Holzer & Holzer, LLC Reminds Investors of - GlobeNewswire
Pomerantz Law Firm Announces the Filing of a Class Action Against Alto Neuroscience, Inc. and Certain Officers – ANRO - FinancialContent
ALTO NEUROSCIENCE, INC. (NYSE: ANRO) SHAREHOLDER ALERT: - GlobeNewswire
Levi & Korsinsky Notifies Shareholders of Alto Neuroscience, Inc.(ANRO) of a Class Action Lawsuit and an Upcoming Deadline - PR Newswire
Will Alto Neuroscience Inc. face regulatory challenges2025 Fundamental Recap & Free Real-Time Market Sentiment Alerts - خودرو بانک
Chart overlay techniques for tracking Alto Neuroscience Inc.GDP Growth & Stock Portfolio Risk Control - Newser
Levi & Korsinsky Urges Alto Neuroscience, Inc. (ANRO) Shareholders to Act Before Lead Plaintiff Deadline September 19, 2025 - ACCESS Newswire
ANRO Investors Have Opportunity to Lead Alto Neuroscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm - WV News
Will Alto Neuroscience Inc. outperform tech stocks2025 Fundamental Recap & Safe Entry Zone Tips - khodrobank.com
ANRO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
What are Alto Neuroscience Inc.’s recent SEC filings showingDividend Hike & Low Drawdown Trading Techniques - خودرو بانک
Visual trend scoring systems applied to Alto Neuroscience Inc.Market Volume Summary & Free Technical Pattern Based Buy Signals - Newser
ANRO Deadline: ANRO Investors with Losses in Excess of $100K Have Opportunity to Lead Alto Neuroscience, Inc. Securities Fraud Lawsuit - PR Newswire
Will earnings trigger a reversal in Alto Neuroscience Inc.July 2025 Sentiment & Stock Market Timing Techniques - Newser
Applying Elliott Wave Theory to Alto Neuroscience Inc.Quarterly Performance Summary & Verified Stock Trade Ideas - Newser
Earnings visualization tools for Alto Neuroscience Inc.July 2025 Opening Moves & Scalable Portfolio Growth Ideas - Newser
Can momentum traders help lift Alto Neuroscience Inc.2025 Historical Comparison & AI Powered Buy and Sell Recommendations - Newser
Historical volatility pattern of Alto Neuroscience Inc. visualizedJuly 2025 Market Mood & Safe Swing Trade Setups - Newser
Bragar Eagel & Squire, P.C. Reminds Investors of Class - GlobeNewswire
ANRO DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, - GlobeNewswire
Alto Neuroscience Class Action Lawsuit: Lead Plaintiff Deadline Approaches - AInvest
ANRO DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Alto Neuroscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
News impact scoring models applied to Alto Neuroscience Inc.2025 Market WrapUp & Free Technical Confirmation Trade Alerts - Newser
Class Action Lawsuit Alert: Levi & Korsinsky Reminds Alto Neuroscience, Inc. (ANRO) Investors of September 19, 2025 Deadline - ACCESS Newswire
Using fundamentals and technicals on Alto Neuroscience Inc.Day Trade & Real-Time Stock Price Movement Reports - Newser
Quant Tools Rank Alto Neuroscience Inc. as High Risk High Reward getLinesFromResByArray error: size == 0 - sisain.net
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Alto Neuroscience - GlobeNewswire
Investors SueWallSt as Alto Neuroscience, Inc. Faces Securities Fraud Allegations - Nasdaq
Shareholders that lost money on Alto Neuroscience, Inc.(ANRO) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More - GlobeNewswire
Shareholders that lost money on Alto Neuroscience, - GlobeNewswire
Alto Neuroscience Inc Azioni (ANRO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):